| |
|
|
|
Kazia Therapeutics Limited  
|
|
3.3818 -0.068 (-0.02%) |
04-18 15:50 |
|
Open: |
3.22 |
Pre close: |
3.45 |
Target:
|
4.44
|
|
High: |
3.434 |
Low: |
3.22 |
Resistance:
|
3.80
4.17
|
|
Volume: |
2,986 |
Market Cap: |
20M |
Support:
|
3.20
2.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.42
 |
MACD |
MACD(12,26):
|
-0.04  |
|
MA(20): |
3.41 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
3.12 |
Stochastic Oscillator |
%K(14,3):
|
31.66 |
|
MA(250): |
3.48 |
%D(3): |
32.63 |
|
Average Volume(K) |
3-Month: |
500
|
52-Week |
High:
|
5.72 |
|
10-Days: |
121 |
Low: |
2.04 |
|
RSI |
RSI(14):
|
46.83 |
Change(%): |
-36.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-26.1 |
Shares Out. (M) |
4.84 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-18.2 |
Shares Float (M) |
4.82 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-47.0 |
% Held by Institutions |
4.70 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.200 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.82 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
